Tobb explains that it lowers glucose production in the liver and improves insulin sensitivity in the muscles, which can help stabilize blood sugar and helps reduce appetite in some people
7, 2025 Journal of Obesity, A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity, May 10, 2024 KFF, Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford, Nov
For example, semaglutide can reduce N-terminal pro brain natriuretic peptide (NT proBNP) by 30% in heart failure patients with preserved ejection fraction (HFpEF), and reduce the risk of cardiovascular death and hospitalization due to heart failure by 31%
He added that many insurance plans for higher earners have also started to cover GLP-1 drugs
There is no clinical evidence that GLP-1 patches help with diabetes
However, due to discrepancies in findings from clinical trials, real-world data, and fundamental research, definitive recommendations for diabetic retinopathy screening prior to GLP-1 RA treatment initiation remain elusive
